Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C

Subjects

Subjects :

Hepatitis C -- Care and treatment
Hepatitis C -- Complications and side effects
Hepatitis C -- Patient outcomes
Hepatitis C -- Research
Protease inhibitors -- Dosage and administration
Protease inhibitors -- Research
Insulin resistance -- Research
Health

Details

Language :

English

ISSN :

00175749

Volume :

59

Issue :

12

Database :

Gale General OneFile

Journal :

Gut

Publication Type :

Academic Journal

Accession number :

edsgcl.247277842